CVS Health: Glenview's Activism Ramps Up Pressure On Management
CVS Health's stock remains significantly undervalued by most metrics, even if management are struggling to unlock value.
Fierce Healthcare3d
Glenview Capital says it's not pushing CVS to break up
A key hedge fund investor for CVS Health will meet with the company's top brass today in a move that signals a potential ...
Modern Healthcare2d
CVS execs have been weighing options for months amid rising costs
CVS has been reviewing its strategic options for months as rising medical costs in its Aetna insurance arm weigh on the ...
STAT4d
Pharmalittle: We’re reading about CVS under investor pressure, a final warning to J&J and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...
Report: Hedge fund CEO pitches improvement plan to CVS execs
A major investor is reportedly meeting with CVS executives today amid growing impatience with the company's financial ...
National pharmacy chain plans to layoff nearly 3,000 people: What to know
The company laid off about 5,000 workers last year. Despite signs of financial woe, the healthcare conglomerate's CEO said ...
CVS trades higher as activist investor denies push to split the company
Shares of CVS Health Corp (NYSE:CVS) are trading higher on Wednesday after Glenview Capital, an activist investor with a $700 million stake in the company, denied rumors that it is pushing to break up ...
CVS Health Restructuring Analysis: Potential Breakup and Valuation Implications
Morgan Stanley analyst Erin Wright maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...